NYSE:GBS GBS (GBS) Stock Price, News & Analysis $1.26 -0.01 (-0.79%) As of 04/15/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock About GBS Stock (NYSE:GBS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get GBS alerts:Sign Up Key Stats Today's Range$1.26▼$1.3050-Day Range$1.23▼$2.6452-Week Range$0.36▼$2.89Volume40,025 shsAverage Volume955,325 shsMarket Capitalization$18.76 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewGBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.Read More… Remove Ads Receive GBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GBS and its competitors with MarketBeat's FREE daily newsletter. Email Address GBS Stock News HeadlinesAnnexon: With IGOS Study Completion, Pre-BLA Meeting In 1st Half 2025 On DeckApril 15 at 4:09 PM | seekingalpha.comGB's Fearnley claims first ATP main draw win on clayApril 15 at 1:42 AM | msn.comTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 17, 2025 | Porter & Company (Ad)Annexon announces tanruprubart trial meets primary endpointApril 9, 2025 | markets.businessinsider.comAnnexon Highlights Pivotal Data on First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) and Showcases New GBS Education Campaign at American Academy of Neurology (AAN) 2025 Annual MeetingApril 8, 2025 | globenewswire.comBeckley business trying to raise money to help local kid battling Guillain-Barré SyndromeApril 6, 2025 | msn.com'I wasn't going to let what happened define me'April 5, 2025 | bbc.comGuillain-Barré Syndrome: This common food habit could be increasing your risk of deadly nerve attacksApril 3, 2025 | msn.comSee More Headlines GBS Stock Analysis - Frequently Asked Questions How have GBS shares performed this year? GBS's stock was trading at $1.40 at the beginning of 2025. Since then, GBS stock has decreased by 10.0% and is now trading at $1.26. View the best growth stocks for 2025 here. How were GBS's earnings last quarter? GBS Inc. (NYSE:GBS) issued its quarterly earnings results on Wednesday, August, 31st. The company reported ($0.14) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.18) by $0.04. How do I buy shares of GBS? Shares of GBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of GBS own? Based on aggregate information from My MarketBeat watchlists, some other companies that GBS investors own include Athenex (ATNX), Biora Therapeutics (BIOR), Citius Pharmaceuticals (CTXR), KLX Energy Services (KLXE), BSQUARE (BSQR), Communications Systems (JCS) and Meta Platforms (META). Company Calendar Last Earnings8/31/2022Today4/16/2025Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNYSE:GBS CIK1725430 Webwww.gbs.inc Phone646 828 8258FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.56) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,310,000.00 Net MarginsN/A Pretax Margin-1,907.09% Return on Equity-85.64% Return on Assets-54.42% Debt Debt-to-Equity RatioN/A Current Ratio2.33 Quick Ratio2.33 Sales & Book Value Annual Sales$440,000.00 Price / Sales42.64 Cash FlowN/A Price / Cash FlowN/A Book Value$0.44 per share Price / Book2.86Miscellaneous Outstanding Shares14,890,000Free Float14,850,000Market Cap$18.76 million OptionableNot Optionable Beta1.32 20 Stocks to Sell NowGet This Free Report This page (NYSE:GBS) was last updated on 4/17/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GBS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GBS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.